Biomarkers for anxiety and depression in cancer patients
Part of Mental health clinical trials.
This study looks for markers in the blood or tissue that might be linked to anxiety and depression in people with solid tumors. By joining, you may help doctors understand these emotional symptoms better and possibly improve support for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old and expected to live at least 3 months or more.
- You have a solid tumor, such as liver cancer or other types confirmed by biopsy or imaging.
- You are not currently taking any anti-anxiety or depression medications, and have not had any psychiatric treatment before the study assessments.
- You are able to understand and complete questionnaires about anxiety and depression (like the SAS and SDS scales).
- You do not have severe mental illness (like schizophrenia or bipolar disorder) or severe organ failure (such as liver or kidney failure).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tracks how anxiety and depression change over time in people with solid tumors. It aims to find risk factors and improve supportive care, while also exploring how much patients understand about their prognosis and want to be involved in decisions.
This study will follow people with cancer over time to learn how anxiety and depression change. It may help doctors understand what support patients need and when.
This study tests a new detection method for depression in people with breast cancer. It uses samples like blood, stool, and saliva to find a link between breast cancer and depression.
This study is looking at a blood marker (a type of chemical change in cells) to see if it can help predict how solid tumor cancers will behave. If you have a solid tumor cancer, this research might help doctors understand your condition better.
This study collects the personal stories and psychological experiences of people with cancer, both during and after treatment, to better understand their needs. If you're receiving or have completed cancer care, your perspective could help improve support for others.
This study looks at “biopsychosocial markers” (biological, psychological, and social signs) in people with major depression and/or anxiety. It aims to understand what changes with treatment and how those changes connect to symptoms like anxiety and depression.
Hear when a new Solid Tumor Malignancies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.